Vaxxinity, Inc.

NASDAQ:VAXX

0.09 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -56.934-75.222-137.175-39.957-14.219
Depreciation & Amortization 2.2341.6841.1020.7170.107
Deferred Income Tax -15.48908.5790.6560
Stock Based Compensation 7.5088.71430.4121.0141.228
Change In Working Capital -8.5439.82212.884-2.7910.157
Accounts Receivables -0.001-0.0210.026-0.026-0.146
Inventory 00.0218.43-0.2440.146
Accounts Payables -3.5122.1032.174-0.267-0.446
Other Working Capital -5.037.7192.254-2.2540.603
Other Non Cash Items 13.986-0.9263.2086.4510.462
Operating Cash Flow -57.238-55.928-80.99-33.91-12.265
Investing Activities:
Investments In Property Plant And Equipment -0.803-1.866-1.318-1.4770
Acquisitions Net -0.0352.526000
Purchases Of Investments -63.942-107.526000
Sales Maturities Of Investments 93.58955000
Other Investing Activites 0.03-52.526000
Investing Cash Flow 28.844-54.392-1.318-1.4770
Financing Activities:
Debt Repayment -1.594-0.43-2.771-5.702-11.12
Common Stock Issued 0.4540.26371.07759.8140.017
Common Stock Repurchased 000-0.0410
Dividends Paid 00000
Other Financing Activities 0-0.167127.86171.85222.24
Financing Cash Flow -1.14-0.167196.16766.10911.137
Other Information:
Effect Of Forex Changes On Cash 00000
Net Change In Cash -29.534-110.487113.85930.722-1.128
Cash At End Of Period 5.03634.57145.05731.1980.476